Åke Svensson
21 – 40 of 168
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Pharmacist recommendations regarding topical steroid use may contradict the standard of care in atopic dermatitis : An international, cross-sectional study
(
- Contribution to journal › Article
-
Mark
Methods to improve quality of life, beyond medicines. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes
(
- Contribution to journal › Article
-
Mark
Penile intraepithelial neoplasia, penile cancer precursors and human papillomavirus prevalence in symptomatic preputium : a cross-sectional study of 351 circumcised men in Sweden
(
- Contribution to journal › Article
-
Mark
Selection process of measures for core outcome set should utilize the highest methodology level and should be maximally free of bias. Comment on ‘IDQoL, CDLQI and the 45-item CADIS received a sufficient content validity rating during the HOME VII meeting in Japan : a group discussion study’
(
- Contribution to journal › Letter
-
Mark
Skin exposure to scented products used in daily life and fragrance contact allergy in the European general population - The EDEN Fragrance Study
(
- Contribution to journal › Article
-
Mark
Intervention study to evaluate the importance of information given to patients with contact allergy : a randomized, investigator-blinded clinical trial*
(
- Contribution to journal › Article
-
Mark
European Task Force on Atopic Dermatitis : position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics
(
- Contribution to journal › Letter
- 2020
-
Mark
Hidradenitis Suppurativa in Sweden : A Registry-Based Cross-Sectional Study of 13,538 Patients
(
- Contribution to journal › Article
-
Mark
European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis
(
- Contribution to journal › Letter
-
Mark
Subjective and Objective Characteristics of Patients Seen at a Psychodermatology Unit : One-year Experience in Malmö, Sweden
(
- Contribution to journal › Article
-
Mark
Tocilizumab-induced sarcoidosis-like reaction in a patient with giant cell arteritis. Clinical implications of a paradoxical phenomenon
(
- Contribution to journal › Letter
-
Mark
Oral provocation of patients allergic to sesquiterpene lactones with German chamomile tea to demonstrate possible systemic allergic dermatitis
(
- Contribution to journal › Article
-
Mark
TREatment of ATopic eczema (TREAT) Registry Taskforce : protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema
(
- Contribution to journal › Article
-
Mark
Validation of a questionnaire algorithm based on repeated open application testing with the constituents of fragrance mix I
(
- Contribution to journal › Article
-
Mark
European Task Force on Atopic Dermatitis (ETFAD) : treatment targets and treatable traits in atopic dermatitis
(
- Contribution to journal › Letter
-
Mark
Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic
(
- Contribution to journal › Article
-
Mark
Associations of self-reported atopic dermatitis with comorbid conditions in adults : a population-based cross-sectional study
(
- Contribution to journal › Article
-
Mark
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
(
- Contribution to journal › Article
-
Mark
Itch and Mental Health in Dermatological Patients across Europe : A Cross-Sectional Study in 13 Countries
(
- Contribution to journal › Article
-
Mark
Prevalence and incidence of atopic dermatitis-a systematic review
(
- Contribution to journal › Scientific review